Literature DB >> 3367181

An application of capture-recapture methods to the estimation of completeness of cancer registration.

S C Robles1, L D Marrett, E A Clarke, H A Risch.   

Abstract

Completeness of cancer registration has not been consistently ascertained across different registries. This report describes how capture-recapture methods have been used to estimate completeness at the Ontario Cancer Registry. The method was applied in two fashions; first, using three data sources in a modeling approach: and second, using two data sources and standard, simple capture-recapture methods. The modeling approach is more flexible, since several variables that influence cancer registration can be considered and can be used to identify reporting patterns of different data sources. In the present analysis, estimates of completeness of the registry as a whole were remarkably similar using either two or three data sources, and site-specific comparisons differed by at most 7%. Because of the advantages of capture-recapture methods-estimation of level of completeness, possible comparability of estimates across different registries, and versatility to consider other determinants of cancer registration-a plea for greater use of these methods in cancer registration is made.

Entities:  

Mesh:

Year:  1988        PMID: 3367181     DOI: 10.1016/0895-4356(88)90052-2

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  131 in total

1.  Capture-recapture method to determine the best design of a surveillance system. Application to a thyroid cancer registry.

Authors:  S Ballivet; L R Salmi; D Dubourdieu
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

2.  Estimating the lesbian population: a capture-recapture approach.

Authors:  D J Aaron; Y-F Chang; N Markovic; R E LaPorte
Journal:  J Epidemiol Community Health       Date:  2003-03       Impact factor: 3.710

Review 3.  Bias in case-control studies. A review.

Authors:  J A Kopec; J M Esdaile
Journal:  J Epidemiol Community Health       Date:  1990-09       Impact factor: 3.710

4.  Why do patients with cancer visit the emergency department near the end of life?

Authors:  Lisa Barbera; Carole Taylor; Deborah Dudgeon
Journal:  CMAJ       Date:  2010-03-15       Impact factor: 8.262

5.  Adoption of adjuvant chemotherapy for non-small-cell lung cancer: a population-based outcomes study.

Authors:  Christopher M Booth; Frances A Shepherd; Yingwei Peng; Gail E Darling; Gavin Li; Weidong Kong; William J Mackillop
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

6.  Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study.

Authors:  Hla-Hla Thein; Edwin Khoo; Michael A Campitelli; Ahmad Zaheen; Qilong Yi; Prithwish De; C C Earle
Journal:  CMAJ Open       Date:  2015-04-02

7.  Quality of end-of-life cancer care in Canada: a retrospective four-province study using administrative health care data.

Authors:  L Barbera; H Seow; R Sutradhar; A Chu; F Burge; K Fassbender; K McGrail; B Lawson; Y Liu; R Pataky; A Potapov
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

8.  Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.

Authors:  Marko Simunovic; Eddy Rempel; Marc-Erick Thériault; Angela Coates; Timothy Whelan; Eric Holowaty; Bernard Langer; Mark Levine
Journal:  Can J Surg       Date:  2006-08       Impact factor: 2.089

9.  Survival of patients with subglottic squamous cell carcinoma.

Authors:  S D MacNeil; K Patel; K Liu; S Shariff; J Yoo; A Nichols; K Fung; A X Garg
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

10.  Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact.

Authors:  A Bouchard-Fortier; N N Baxter; R Sutradhar; K Fernandes; X Camacho; P Graham; M L Quan
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.